Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

After months of rapid respiratory disease spread and sickness, Georgia and Atlanta cases of Covid-19, flu, or RSV appear to ...

A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab ...

Among older adults in Spain, hospitalisation rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more ...

Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

A newly released white paper, based on research conducted independently by IQVIA, a global healthcare consultancy, and ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

From next Monday, 17 March, free immunisation from respiratory syncytial virus (RSV) will be available to all newborn babies.